Laboratory Corporation of America's purchase of Medtox Scientific has been cleared by the US Federal Trade Commission, reports CBS News. LabCorp announced the FTC decision on Friday. On Thursday, Medtox released its second-quarter earnings, saying the company had a net income of $1.2 million and that revenues were up 15.5 percent in its diagnostics business for the quarter.
Medtox shareholders will vote on the $241 million deal with LabCorp on July 31.